Clare Ozawa - Jan 5, 2022 Form 4 Insider Report for Oyster Point Pharma, Inc. (OYST)

Role: Director, 10%+ Owner
Signature: /s/ Robin L. Praeger, Attorney-in-Fact for Clare Ozawa
Stock symbol: OYST
Transactions as of: Jan 5, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/7/2022, 03:18 PM
Previous filing: Dec 23, 2021
Next filing: Jun 8, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OYST	Common Stock	Other	$0	-200K	-32.56%	$0.00	415K	Jan 5, 2022	See Footnotes	F1, F2
transaction	OYST	Common Stock	Other	$0	+51.6K		$0.00	51.6K	Jan 5, 2022	See Footnotes	F3, F4
transaction	OYST	Common Stock	Other	$0	-51.6K	-100%	$0.00^*	0	Jan 5, 2022	See Footnotes	F4, F5
transaction	OYST	Common Stock	Other	$0	+120	+1.1%	$0.00	11.1K	Jan 5, 2022	Direct	F6
transaction	OYST	Common Stock	Other	$0	-1.26K	-33.84%	$0.00	2.47K	Jan 5, 2022	See Footnotes	F7, F8
holding	OYST	Common Stock						2.24M	Jan 5, 2022	See Footnotes	F9
holding	OYST	Common Stock						1M	Jan 5, 2022	See Footnotes	F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. ("Versant IV") to its partners pursuant to a Rule 10b5-1 trading plan.
F2	Shares held by Versant IV. Versant Ventures IV, LLC ("Versant Ventures IV") is the sole general partner of Versant IV. Versant Ventures IV disclaims beneficial ownership of the shares held by Versant IV, except to the extent of its pecuniary interest therein.
F3	Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV.
F4	Shares held by Versant Ventures IV.
F5	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV, to its members.
F6	Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures IV.
F7	Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. ("Versant Side Fund IV") to its partners pursuant to a Rule 10b5-1 trading plan.
F8	Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. Versant Ventures IV disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of its pecuniary interest therein.
F9	Shares held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the sole general partner of Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") and Versant Ventures VI GP is the sole general partner of Versant VI. The Reporting Person, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP and the Reporting Person disclaims beneficial ownership of the shares held by Versant VI, except to the extent of their respective pecuniary interests therein.
F10	Shares held by Versant Vantage I, L.P. ("Versant Vantage"). Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("Versant Vantage I GP") and Versant Vantage I GP is the sole general Partner of Versant Vantage. The Reporting Person, a member of the Issuer's board of directors, is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage. Each of Versant Vantage I GP-GP, Versant Vantage I GP, and the Reporting Person disclaims beneficial ownership of the shares held by Versant Vantage, except to the extent of their respective pecuniary interests therein.